Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing

Autor: Thomas Lang, Alfons O. Hamm, Bettina Pfleiderer, Claus-Jürgen Scholz, Jan Richter, Christiane A. Pané-Farré, Jürgen Deckert, Benjamin Straube, Hans-Ulrich Wittchen, Volker Arolt, Heike Weber, Alexander L. Gerlach, Andreas Ströhle, Paul Pauli, Benedikt Klauke, Christian Jacob, Tilo Kircher, Lydia Fehm, Carsten Konrad, Lindsey Kent, Thomas Fydrich, Andreas Jansen, Peter Zwanzger, Christian Baumann, Ulrike Lueken, André Wittmann, Katharina Domschke, C. Schartner, Andreas Reif, Georg W. Alpers
Přispěvatelé: University of St Andrews. School of Medicine, University of St Andrews. Institute of Behavioural and Neural Sciences
Rok vydání: 2015
Předmět:
Male
0301 basic medicine
Avoidance test
Candidate gene
Hydrocortisone
Corticotropin-Releasing Hormone
Pituitary-Adrenal System
Anxiety
0302 clinical medicine
Risk Factors
Medicine
R2C
Panic disorder
fMRI
~DC~
Fear
Middle Aged
Anxiety Disorders
Association study
Psychiatry and Mental health
Phenotype
Schizophrenia
Panic Disorder
Female
medicine.symptom
BDC
RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Adult
Hypothalamo-Hypophyseal System
medicine.medical_specialty
Genotype
NDAS
Single-nucleotide polymorphism
Polymorphism
Single Nucleotide

Receptors
Corticotropin-Releasing Hormone

03 medical and health sciences
Cellular and Molecular Neuroscience
Bias
Internal medicine
Humans
Genetic Predisposition to Disease
Allele
Molecular Biology
Alleles
business.industry
Genetic Variation
CRHR1
medicine.disease
Minor allele frequency
030104 developmental biology
Endocrinology
MCP
RC0321
Anxiety sensitivity
business
Neuroscience
030217 neurology & neurosurgery
Zdroj: Molecular Psychiatry. 21:813-822
ISSN: 1476-5578
1359-4184
DOI: 10.1038/mp.2015.125
Popis: This work is part of the German multicenter trial ‘Mechanisms of Action in CBT (MAC)’. The MAC study is funded by the German Federal Ministry of Education and Research (BMBF; project no. 01GV0615) as part of the BMBF Psychotherapy Research Funding Initiative. The study was further supported by the DFG (Grant RE1632/5-1 and KFO 125 to AR; SFB TRR 58 Z02 to JD, PP and AR; C02 to JD and KD; DE357/4-1 to JD, AR, JR and AH; RTG 1256 to AR, JD and PP; IZKF-Würzburg Z-6 to HW). Corticotropin releasing hormone (CRH) is a major regulator of the hypothalamicpituitary-adrenal (HPA) axis. Binding to its receptor CRHR1 triggers the downstream release of cortisol, a hormone needed for regulation of stress responses. Biochemical, behavioral and genetic studies revealed CRHR1 as a possible candidate gene for mood and anxiety disorders. Here, we aimed to evaluate CRHR1 as a candidate molecule in panic disorder (PD). Allelic variation throughout the CRHR1 gene was captured by 9 selected single nucleotide polymorphisms (SNPs); these were genotyped in 531 matched case/control pairs (discovery sample (n=239); replication sample (n=292)). Four SNPs were found to be associated with PD, in at least one sub-sample. The minor alleles of rs17689918 and rs17689966 were found to significantly increase risk for PD in females of the discovery, the replication and the combined sample, both withstanding correction for multiple testing (prs17689918=1.3*10-4; prs17689966=0.042). Expressional analysis demonstrated that both minor alleles of rs17689918 and rs17689966 significantly decreased CRHR1 mRNA in the forebrain and amygdala. Bioinformatical analysis revealed a high proportion of differential neuro-relevant transcription factor binding possibly underlying expression changes. When investigating the neural correlates underlying this association, risk allele carriers of rs17689918 and rs17689966 showed aberrant differential conditioning and safety signal processing arguing for predominant generalization of fear and hence anxious apprehension. Furthermore, the minor risk (A) allele of rs17689918 led to less flight behavior during fear provoking situations, but rather increased anxious apprehension and went along with increased anxiety sensitivity. Thus, reduced CRHR1 expression driven by CRHR1 risk allele leads to a phenotype characterized by a fear bias and hence sustained fear. These results strengthen the role of CRHR1 in PD and clarify the mechanisms by which genetic variation in CRHR1 is linked to this disorder. Postprint
Databáze: OpenAIRE